Education
About Us
Working with TipRanks
Follow Us
Poolbeg Pharma Ltd. (GB:POLB)
LSE:POLB
Total Valuation
Poolbeg Pharma Ltd. has a market cap or net worth of £28.59M. The enterprise value is 6.75M.
Market Cap£28.59M
Enterprise Value6.75M
Share Statistics
Poolbeg Pharma Ltd. has 697,200,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding697,200,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Poolbeg Pharma Ltd.’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -73.22%.
Return on Equity (ROE)-0.62
Return on Assets (ROA)-0.57
Return on Invested Capital (ROIC)-73.22%
Return on Capital Employed (ROCE)-0.71
Revenue Per Employee0.00
Profits Per Employee-396.27K
Employee Count15
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Poolbeg Pharma Ltd. is ―. Poolbeg Pharma Ltd.’s PEG ratio is 0.06.
PE Ratio―
PS Ratio0.00
PB Ratio3.82
Price to Fair Value3.82
Price to FCF-7.42
Price to Operating Cash Flow-4.34
PEG Ratio0.06
Income Statement
In the last 12 months, Poolbeg Pharma Ltd. had revenue of 0.00 and earned -5.79M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit-114.00K
Operating Income-6.62M
Pretax Income-5.94M
Net Income-5.79M
EBITDA-6.00M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -4.73M and capital expenditures 0.00, giving a free cash flow of -4.73M billion.
Operating Cash Flow-4.73M
Free Cash Flow-4.73M
Free Cash Flow per Share>-0.01
Dividends & Yields
Poolbeg Pharma Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change-42.66%
50-Day Moving Average3.78
200-Day Moving Average3.32
Relative Strength Index (RSI)59.34
Average Volume (3m)1.12M
Important Dates
Poolbeg Pharma Ltd. upcoming earnings date is Feb 26, 2026, TBA (Not Confirmed).
Last Earnings DateSep 29, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend Date―
Financial Position
Poolbeg Pharma Ltd. as a current ratio of 8.79, with Debt / Equity ratio of 0.00%
Current Ratio8.79
Quick Ratio8.79
Debt to Market Cap0.00
Net Debt to EBITDA1.30
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Poolbeg Pharma Ltd. has paid 154.00K in taxes.
Income Tax154.00K
Effective Tax Rate-0.03
Enterprise Valuation
Poolbeg Pharma Ltd. EV to EBITDA ratio is -4.60, with an EV/FCF ratio of -5.78.
EV to Sales0.00
EV to EBITDA-4.60
EV to Free Cash Flow-5.78
EV to Operating Cash Flow-5.94
Balance Sheet
Poolbeg Pharma Ltd. has £9.96M in cash and marketable securities with £0.00 in debt, giving a net cash position of £9.96M billion.
Cash & Marketable Securities£9.96M
Total Debt£0.00
Net Cash£9.96M
Net Cash Per Share£0.01
Tangible Book Value Per Share£0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Poolbeg Pharma Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―